These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2944534)

  • 1. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa.
    Mortimer PS; Dawber RP; Gales MA; Moore RA
    Br J Dermatol; 1986 Sep; 115(3):263-8. PubMed ID: 2944534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy.
    Sawers RS; Randall VA; Ebling FJ
    Br J Dermatol; 1986 Sep; 115(3):269-74. PubMed ID: 2944535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyproterone acetate and two doses of oestrogen in female acne; a double-blind comparison.
    Colver GB; Mortimer PS; Dawber RP
    Br J Dermatol; 1988 Jan; 118(1):95-9. PubMed ID: 2963663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment.
    Greenwood R; Brummitt L; Burke B; Cunliffe WJ
    Br Med J (Clin Res Ed); 1985 Nov; 291(6504):1231-5. PubMed ID: 2933119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Influence on androgens in the serum and urine and on urinary cortisol].
    Nielsen DR; Larsen J; Pedersen IM; Starup J
    Ugeskr Laeger; 1985 Aug; 147(33):2589-93. PubMed ID: 2933857
    [No Abstract]   [Full Text] [Related]  

  • 7. Hidradenitis suppurativa: an androgen-dependent disorder.
    Ebling FJ
    Br J Dermatol; 1986 Sep; 115(3):259-62. PubMed ID: 3756090
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-androgen treatment in women with acne: a controlled trial.
    Miller JA; Wojnarowska FT; Dowd PM; Ashton RE; O'Brien TJ; Griffiths WA; Jacobs HS
    Br J Dermatol; 1986 Jun; 114(6):705-16. PubMed ID: 2941052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Evaluation of the clinical effect].
    Pedersen IM; Nielsen DR; Larsen J; Starup J
    Ugeskr Laeger; 1985 Aug; 147(33):2594-6. PubMed ID: 2933858
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane].
    Aydinlik S; Lachnit-Fixson U; Lehnert J
    Fortschr Med; 1986 Jul; 104(27-28):547-50. PubMed ID: 2943651
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parameters.
    Parr JH; Seed M; Godsland I; Wynn V
    J Endocrinol Invest; 1987 Jun; 10(3):237-9. PubMed ID: 2957418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of isotretinoin treatment of hidradenitis suppurativa.
    Dicken CH; Powell ST; Spear KL
    J Am Acad Dermatol; 1984 Sep; 11(3):500-2. PubMed ID: 6384295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A cyproterone acetate-ethinyl estradiol combination in the treatment of acne. Data of a survey of gynecologists].
    Vignini M; Pelfini C; Montanari L
    Minerva Ginecol; 1988 Feb; 40(2):125-32. PubMed ID: 2969466
    [No Abstract]   [Full Text] [Related]  

  • 14. [Multicentric clinical trial of a combination of 35 micrograms of ethinylestradiol and 2 mg of cyproterone acetate].
    Audebert A; Emperaire JC; Gauthier A; Hallonet P; Hedon B; Lopes P; Quereux C; Roulier R
    Rev Fr Gynecol Obstet; 1991 Nov; 86(11):697-9. PubMed ID: 1838208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiandrogens and hirsutism.
    Biffignandi P; Molinatti GM
    Horm Res; 1987; 28(2-4):242-9. PubMed ID: 2969862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-androgen treatment of hirsutism with cyproterone acetate].
    Kása M; Egyedi K; Raffai S; Török L
    Z Hautkr; 1990 Dec; 65(12):1112-4. PubMed ID: 2150902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced serum vitamin B12 levels during oral cyproterone-acetate and ethinyl-oestradiol therapy in women with diffuse androgen-dependent alopecia.
    Ramsay ID; Rushton DH
    Clin Exp Dermatol; 1990 Jul; 15(4):277-81. PubMed ID: 2145099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic cyproterone/ethinyloestradiol for acne.
    Lancet; 1983 Aug; 2(8347):458. PubMed ID: 6135942
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclic cyproterone/ethinyloestradiol in acne.
    Bye P
    Lancet; 1983 Oct; 2(8355):910-1. PubMed ID: 6137719
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of cyproterone acetate on rate of hair growth in hirsute females.
    Jones KR; Katz M; Keyzer C; Gordon W
    Br J Dermatol; 1981 Dec; 105(6):685-92. PubMed ID: 6459114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.